Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
Top Cited Papers
Open Access
- 14 January 2010
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 115 (2), 379-387
- https://doi.org/10.1182/blood-2009-05-221549
Abstract
Factor H autoantibodies have been reported in approximately 10% of patients with atypical hemolytic uremic syndrome (aHUS) and are associated with deKeywords
This publication has 28 references indexed in Scilit:
- The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic SyndromeThe Journal of Immunology, 2009
- Mutations in complement C3 predispose to development of atypical hemolytic uremic syndromeBlood, 2008
- The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2008
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domainsThe Journal of Experimental Medicine, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLoS Genetics, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement GenePLoS Medicine, 2006
- Atypical haemolytic uraemic syndromeBritish Medical Bulletin, 2006
- Does complement factor B have a role in the pathogenesis of atypical HUS?Molecular Immunology, 2006
- An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutationsHuman Mutation, 2005